Evidence for Action: COVID-19 as a Window of Opportunity to Normalize Medications for Opioid Use Disorder Access
- Funded by FORE
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
20212022Known Financial Commitments (USD)
$230,357Funder
FOREPrincipal Investigator
MDiv. Beth MeyersonResearch Location
United States of AmericaLead Research Institution
Southwest Institute for Research on WomenResearch Priority Alignment
N/A
Research Category
Health Systems Research
Research Subcategory
Health service delivery
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
This project will assess whether and how providers in Arizona implemented COVID-19-era policies related to MOUD provision and telehealth, and how these policies have affected patients' access to treatment and outcomes. The project investigators will engage with tribal leaders as well as state policymakers, providers, and patient advisory boards; their findings will inform longer-term efforts to promote more equitable access to treatment for all Arizonans.